Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Chemoradiation in Cervical Cancer
NCT00292955Phase 2Unknown
- Sponsor
- University of Virginia
- Start
- Feb 2006
- Primary completion
- Feb 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in cervical carcinoma, sponsored by University of Virginia. Status: unknown.
02
Drugs
cetuximab
03
Conditions
cervical carcinoma
Beyond the preview
Go deeper on NCT00292955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00292955.